As Nation Awaits Vaccine, Biden Is Under Pressure to Name New FDA Chief ASAP
It typically takes months to install new leadership, but with COVID deaths set to surge through the winter, many Democrats say Biden doesn’t have that sort of time.
Vaccines
721 - 740 of 828 Results
-
-
VA Joins Pentagon in Recruiting Volunteers for COVID Vaccine Trials
The Department of Veterans Affairs hopes to enroll 8,000 people in advanced-stage trials of four leading vaccine candidates. The Defense Department earlier announced plans to enlist 3,000 volunteers in trials.
-
KHN’s ‘What the Health?’: As Cases Spike, White House Declares Pandemic Over
Former President Barack Obama says President Donald Trump is “jealous of COVID’s media coverage.” Indeed, Trump has complained at his rallies, attended by mostly maskless supporters, about how the media covers the pandemic — at a time when cases are rising rapidly across the nation. Meanwhile, open enrollment is about to begin for the Affordable Care Act in a year when many people need coverage, but the law’s future is not secure. Joanne Kenen of Politico, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Anna Almendrala about the latest KHN-NPR “Bill of the Month” installment.
-
Scientists Warn Americans Are Expecting Too Much From a Vaccine
Some argue that vaccines capable of preventing any COVID-19 symptoms should qualify for widespread use, but others want much larger trials to prove the vaccines can reduce hospitalizations or deaths.
By Liz Szabo and JoNel Aleccia -
KHN on the Air This Week
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Analysis: Winter Is Coming for Bars. Here’s How to Save Them. And Us.
To stop the coronavirus, we need to stop super-spreader events.
-
KHN’s ‘What the Health?’: Trump vs. COVID
President Donald Trump is one of at least two dozen people tied to the White House who have tested positive for COVID-19. Negotiations on the next round of COVID relief are off again — maybe. And the FDA and CDC continue to fight for scientific credibility. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Erin Mershon of Stat News join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews Amy Howe of SCOTUSblog about what the Supreme Court might do with the latest case challenging the constitutionality of the Affordable Care Act.
-
In Debate, Pence and Harris Offer Conflicting Views of Nation’s Reality
During this, the first and only vice presidential debate of the 2020 election season, the two candidates clashed over the coronavirus and other health care issues, as well as a range of other topics.
-
Distrusting Trump, States Plan to Vet COVID Vaccines Themselves. Bad Idea, Say Experts.
California and at least five other states have said they may independently vet any vaccines. Experts warn that could needlessly confuse the public.
By JoNel Aleccia and Liz Szabo -
5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’
Approval of a vaccine will be an important step in defeating COVID-19. But it won’t immediately end the pandemic.
-
These Secret Safety Panels Will Pick the COVID Vaccine Winners
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
-
Signs of an ‘October Vaccine Surprise’ Alarm Career Scientists
President Donald Trump has the legal power to authorize a COVID vaccine over the objections of the Food and Drug Administration and vaccine manufacturers. Such a move could further erode public trust in a vaccine and foist an unsafe shot on Americans.
By Liz Szabo and JoNel Aleccia -
KHN on the Air This Week
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
COVID Vaccine Trials Move at Warp Speed, But Recruiting Black Volunteers Takes Time
The National Institutes of Health has suggested minorities should be overrepresented in COVID-19 vaccine trials — perhaps at rates that are double their percentage of the U.S. population. But efforts to recruit patients from racial minority groups are just beginning, while some trials have already advanced to phase 3.
-
NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial
The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurological condition is linked to the vaccine. But regulators are frustrated by a lack of information from the drugmaker.
By Arthur Allen and Liz Szabo -
Readers and Tweeters Grapple With COVID Therapies and Forecasts
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
KHN’s ‘What the Health?’: The Politics of Science
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.
-
Most Adults Wary of Taking Any Vaccine Approved Before the Election
About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.
By Jordan Rau -
With Schools Starting Online, Vaccinations Head for Recess
Traditionally, requirements that kids undergo certain immunizations before attending school have been a critical public health tool. Health officials are scrambling to make sure children don’t fall through the cracks.
-
As Threat of Valley Fever Grows Beyond the Southwest, Push Is On for Vaccine
Efforts are underway to bring to market a vaccine for valley fever, a fungal infection with COVID-like symptoms that occurs in the deserts of the Southwest. The illness is getting more attention as cases rise and a warming climate threatens to spread it through the West.
By Jim Robbins